Development of Phage Display Technology: A Bibliometric Assessment

Puzzling Peptides from a Phage Display Library

The commercial availability of random peptide libraries displayed on the M13 phage is increasing their use forstudies on epitope identification, enzyme inhibitors, receptor ligands, etc. In this study two experimentswhere planned for selection of peptides. First with sheep antibodies, the positive selector was IgG, preparedon Protein G column from a pool of 11 sheeps immunized...

Discovery of Novel Peptidomimetics for Brain-Derived Neurotrophic Factor using Phage Display Technology

Brain-Derived Neurotrophic Factor (BDNF) is a neuroprotectant candidate for neurodegenerative diseases. However, there are several clinical concerns about its therapeutic applications. In the current study, we selected BDNF-mimicking small peptides from phage-displayed peptide library as alternative molecules to the clinical challenges. The peptide library was screened against BDNF receptor (Ne...

Antibody engineering and phage display technology

Antibodies are an essential biotechnological tool being a part of immunodiagnostics, therapeutics and life science research instruments. Due to the advances of molecular biology methods, it became possible to manipulate structure and properties of antigen-binding domains of antibodies (1). This led to the creation of a variety of small-sized, single-domain, bi-specific, conjugated antibodies, a...

Phage display technology - Applications and innovations

The expression of exogenous peptides on the surface of filamentous bacteriophage was initially described by Smith in 1985. Since his first study, different molecules such as small peptides and antibodies have been displayed on coat proteins of phage, greatly expanding the applications of the technology. The past decade has seen considerable progress in the techniques and applications of phage l...

Phage Display Technology for Surface Functionalization of a Synthetic Biomaterial